Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01387113 · ClinicalTrials.gov registry record

The PERFusion Use in Stroke Evaluation Study

A clinical trial of Ischemic Stroke, sponsored by California Pacific Medical Center Research Institute.

Completed
Registry status
48
Enrollment target
1
Study location

NCT01387113 is a study of Ischemic Stroke that has completed, run by California Pacific Medical Center Research Institute. The registered enrollment target is 48 participants, below the 1,463-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01387113, a study of Ischemic Stroke, has completed, sponsored by California Pacific Medical Center Research Institute.

COMPLETED
Registry status
48 participants
Enrollment target
1
Study location

Study Summary

This is an open label single center phase II trial, evaluating the utility of 64 slice CT perfusion (CTP) in acute ischemic stroke (AIS) patients. The main aim is to determine which aspects of CTP imaging can aid in expanding the time window for thrombolysis with IV (rt-PA) in AIS patients up to 6 hours after symptom onset.

Conditions Studied

Interventions

  • OTHER Computed tomography perfusion imaging

Study Locations (1)

California

  • California Pacific Medical Center - San Francisco

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2011-05
Est. Completion 2022-07

What the Registry Record Tells You About NCT01387113

The ClinicalTrials.gov registry entry for NCT01387113 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,463-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (97% lower). The listed sponsor is California Pacific Medical Center Research Institute, which has 29 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Ischemic Stroke appearing as the primary indexed condition, and to 1 intervention - of which Computed tomography perfusion imaging is the first listed.

NCT01387113 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01387113 about?

NCT01387113 is a clinical study titled "The PERFusion Use in Stroke Evaluation Study". This is an open label single center phase II trial, evaluating the utility of 64 slice CT perfusion (CTP) in acute ischemic stroke (AIS) patients. The main aim is to determine which aspects of CTP imaging can aid in expanding the time window for thrombolysis with IV (rt-PA) in AIS patients up to 6 h...

What is the current status of trial NCT01387113?

This trial is currently completed. The enrollment target is 48 participants. The study started on 2011-05. Estimated completion is 2022-07.

What conditions does trial NCT01387113 study?

This clinical trial studies the following conditions: Ischemic Stroke.

What interventions are being tested in trial NCT01387113?

The interventions under investigation include: Computed tomography perfusion imaging (OTHER).

Who is sponsoring clinical trial NCT01387113?

This trial is sponsored by California Pacific Medical Center Research Institute, which has 29 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01387113 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Ischemic Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.